Gene Data From HGNC: https://www.genenames.org/download/statistics-and-files/
Symbol:
FGF23
Name:
fibroblast growth factor 23
Location:
12p13.32
Locus Group:
protein-coding gene
Gene Type:
Protein Coding
Locus Type:
gene with protein product
Clinical Trials Data: https://classic.clinicaltrials.gov/api/gui/ref/download_all
Clinical Studies
| NCT Number | Status | Brief Title | View |
|---|---|---|---|
| NCT01283945 | Study of Oral Lucitanib E-3810 a Dual VEGFR-FGFR Tyrosine Kinase Inhibitor in Patients With Solid Tumors | View | |
| NCT00843349 | Fibroblast Growth Factor-23 FGF23 Reduction in Predialysis Chronic Kidney Disease CKD | View | |
| NCT05258370 | Fibroblast Growth Factor 23 in Chronic Respiratory Failure | View | |
| NCT01317186 | The Role of FGF23 and Asymmetric Dimethylarginine ADMA in Chronic Kidney Disease | View | |
| NCT01526304 | The Role Of FGF23 Klotho And Sclerostin In Kidney Stone Formers | View | |
| NCT01748812 | Cinacalcet for Fibroblast Growth Factor 23 FGF23-Mediated Hypophosphatemia Hypophosphatemic Rickets | View | |
| NCT02440581 | Renal Osteodystrophy An Individual Management Approach | View | |
| NCT02822131 | Phosphate in Blood Pressure Regulation | View | |
| NCT03193073 | Anemia Correction and Fibroblast Growth Factor 23 Levels in Chronic Kidney Disease and Renal Transplant Patient | View | |
| NCT03489993 | FGF23 and Angiotensin-1-7 in Hypophosphatemia GAP | View | |
| NCT03581591 | Open Label Trial Assessing Safety and Efficacy of Burosumab KRN23 in a Patient With ENS and Hypophosphatemic Rickets | View | |
| NCT00305279 | The Effects of Dietary Phosphate Intake on Calciotropic Hormones and FGF23 | View | |
| NCT03648736 | Time Course of Circulating Myocardial Biomarkers After a TASH Procedure | View | |
| NCT04674397 | BOne Dysfunction in Donor NEphrectomieS | View | |
| NCT04132492 | AGNES - Aging Nephropathy Study a Prospective Observational Cohort of Chronic Kidney Disease in Elderly Patients | View | |
| NCT04159675 | Burosumab and 1-25 OH Vitamin D on Human Osteoblasts | View | |
| NCT04184661 | Burosumab and 1-25 OH Vitamin D on Human Osteoclasts | View | |
| NCT04320316 | A Trial to Assess the Safety and Efficacy of KRN23 in Epidermal Nevus Syndrome ENS | View | |
| NCT04961931 | Effect of Empagliflozin on Urinary Excretion of Adenosine and Osteocyte Function in Patients With Chronic Kidney Disease | View | |
| NCT05356325 | FGF23 and Cardiovascular Damage in Anemia With an Without Chronic Kidney Disease | View | |
| NCT06248632 | Effect of Burosumab on the Inflammatory Profile of Patients With X-linked Hypophosphatemic Rickets FLAM-XLH | View | |
| NCT02404870 | Acute Effects of Canagliflozin a Sodium Glucose Co-Transporter 2 SGLT2 Inhibitor on Bone Metabolism in Healthy Volunteers | View | |
| NCT03307707 | New Heart Failure Biomarkers in Early Stage Chronic Kidney Disease-Mineral and Bone Disorder | View | |
| NCT03464149 | The Longitudinal PTH-Study | View | |
| NCT01660308 | Observing the Changes of Fibroblast Growth Factor 23 in Patients of Tumor Induced Osteomalacia | View | |
| NCT00491322 | Vitamin D Deficiency Insulin Resistance and FGF-23 | View | |
| NCT01317173 | Factors Related to the Progression of Chronic Kidney Disease | View | |
| NCT00187629 | Phosphate Intakes Effect on the Skeletal System - Pilot | View | |
| NCT02812134 | Impact of Oral Phosphorus Supplements on the 6-month Change in FGF23 Levels in Anorexic Adolescents Suffering From Undernutrition | View | |
| NCT02708368 | SOPs for CKD-MBD-Biomarkers | View | |
| NCT01002872 | The Effect of Lanthanum Carbonate on Fibroblast Growth Factor 23 FGF23 in Chronic Kidney Disease | View | |
| NCT01752920 | Phase 12 Study of Derazantinib ARQ 087 in Adult Subjects With Advanced Solid Tumors With FGFR Genetic Alterations | View | |
| NCT01703234 | FGF-23 and Endothelial Dysfunction in Diabetic Proteinuric Patients | View | |
| NCT04695860 | Anti-FGF23 Burosumab in Adult Patients With XLH | View | |
| NCT01128179 | Effects of Lanthanum Carbonate on FGF-23 in Subjects With Stage 3 CKD | View | |
| NCT04741646 | Ferric Citrate and Chronic Kidney Disease in Children | View | |
| NCT01738945 | Effect of Calcium Channel Blocker on the Serum Fibrobalst Growth Factor-23 FGF-23 Levels in Type-2 Diabetic Patients With Proteinuria Purpose | View | |
| NCT01180946 | Vitamin D Deficiency in Adolescent Girls | View | |
| NCT01231438 | Treatment of Early Stage Renal Failure With Active Vitamin D or a Phosphate Binder | View | |
| NCT01741116 | DovitinibTKI258 in Patients With Castration-resistant Prostate Cancer | View | |
| NCT01308242 | Effects of a Non-Calcium Based Phosphate Binder on FGF23 Levels in Chronic Kidney Disease | View | |
| NCT01475760 | A Study to Evaluate Chitosan Chewing Gum in Patients With Chronic Kidney Disease | View | |
| NCT02951442 | Identification of Markers Klotho-FGF23 Axis as Determinant in the Evolution of Arterial Stiffness During the First Year of Renal Transplant | View | |
| NCT01652573 | Calcitonin for Treating X-linked Hypophosphatemia | View | |
| NCT01748396 | Effect of Phosphate Binders on FGF-23 With Concurrent Calcitriol | View | |
| NCT03310684 | Pediatric Primary Hypertension and the Renin-Angiotensin System PHRAS | View | |
| NCT01845090 | The Effect of Lanthanum Carbonate on Fibroblast Growth Factor 23 | View | |
| NCT01801501 | Role of FGF-23 as a Prognosis Biomarker in Intensive Care Patients | View | |
| NCT01974713 | Inflammatory Markers and Adverse Outcomes in Chronic Kidney Disease | View | |
| NCT02665117 | Preventing Metabolic Side Effects of Thiazide Diuretics With KMgCitrate | View | |
| NCT03367338 | Low-Phosphate Diet and Fibroblast Growth Factor-23 Level | View | |
| NCT05357573 | Study to Assess the Safety Pharmacokinetics and Efficacy of KRN23 in Adult Chinese Patients With TIO | View | |
| NCT02233322 | Iron Therapy for Autosomal Dominant Hypophosphatemic Rickets A Pilot Project | View | |
| NCT02258074 | The COMBINE Study The CKD Optimal Management With BInders and NicotinamidE | View | |
| NCT02331966 | Molecular Pathways Involved in the Pathogenesis and Behavior of Mesenchymal Phosphaturic Tumors Causing Oncogenic Osteomalacia | View | |
| NCT05549154 | A Study on Prevention Strategies for CKD-SHPT and Related Complications Based on General Vitamin D Supplementation | View | |
| NCT03532568 | Klotho in Chronic Kidney Disease-associated Pruritis CKD-aP | View | |
| NCT03550534 | The Effectiveness and Safety of Calcium Carbonate in Chronic Kidney Disease With Normophosphatemia | View | |
| NCT02492620 | Ferric Citrate for the Transition From CKD Stage 45 to CKD Stage 5D | View | |
| NCT02526160 | Study of KRN23 in Adults With X-linked Hypophosphatemia XLH | View | |
| NCT02537431 | Open Label Study of KRN23 on Osteomalacia in Adults With X-linked Hypophosphatemia XLH | View | |
| NCT05757271 | Serum Levels of Klotho as a Possible Biomarker of Peripheral Artery Disease | View | |
| NCT03651505 | X-linked Hypophosphatemia Disease Monitoring Program | View | |
| NCT02891954 | Genetics of Response to Canagliflozin | View | |
| NCT02918591 | Cardiovascular Effects of Empagliflozine | View | |
| NCT02958839 | Relationship Between Fibroblast Growth Factor 23 and Recurrence of Atrial Fibrillation After Catheter Ablation | View | |
| NCT03079518 | Intravenous Iron in paTients With Heart failURe and Reduced Ejection fracTion HFREF pLus Iron dEficiency | View | |
| NCT03106298 | Iron Deficiency and FGF23 Regulation in CKD and HF | View | |
| NCT03173235 | Plasma Concentrations of Calcium Phosphate FGF23 Klotho 25 OH D3 and 125 OH 2D3 From Patients Who Wants to Have Children | View | |
| NCT03510455 | BGJ398 for the Treatment of Tumor-Induced Osteomalacia | View | |
| NCT03565913 | Potential Therapeutic Role of Effervescent Calcium-Magnesium Citrate in Chronic Kidney Disease Stage V | View | |
| NCT04693962 | FGF23 as a Marker of Acute Kidney Injury | View | |
| NCT03628443 | Cardiorenal Risk Stratification Pilot Study | View | |
| NCT03803514 | Effect of rEPO in FGF23 in ESRD Patients | View | |
| NCT04273490 | Characterising Pain QoL Body Composition Arterial Stiffness Muscles and Bones in Adult Persons With XLH and Healthy Controls | View | |
| NCT02792868 | Biological Phosphocalcic Metabolism and Coronary Artery Calcifications | View | |
| NCT06002529 | Hemodiafiltration With Endogenous Reinfusion on Uremic Toxins Clearance of Maintenance Hemodialysis Patients | View | |
| NCT04842019 | Study to Assess the Safety Pharmacokinetics and Efficacy of KRN23 in Adult Chinese Patients With XLH | View | |
| NCT04846647 | Study of the Inappropriate Secretion of FGF23 in Patients Followed in Hospital in a Context of Hypophosphatemia | View | |
| NCT04842032 | Study to Assess the Safety Pharmacokinetics and Efficacy of KRN23 in Pediatric Chinese Patients With XLH | View | |
| NCT05275491 | Fibroblast Growth Factor 23 and Sclerostin in Relation to Calcium in COVID-19 Patients | View | |
| NCT05556499 | The Bone-parathyroid Crosstalk in Primary Hyperparathyroidism | View | |
| NCT02040740 | Mediators of Kidney-Bone Communication in Childhood | View | |
| NCT05854576 | Markers of Metabolism and Vascular Access in ESRD | View | |
| NCT00957879 | Different Vitamin D Preparations FGF23 in Humans | View | |
| NCT01135615 | Sevelamer FGF-23 and Endothelial Dysfunction in Chronic Kidney Disease CKD | View | |
| NCT01220843 | FGF23 Reduction Efficacy of a New Phosphate Binder in CHronic Kidney Disease | View | |
| NCT01311973 | Salivary Phosphorus and Level of Kidney Function | View | |
| NCT03920072 | Study of the Anti-FGF23 Antibody Burosumab in Adults With XLH | View | |
| NCT02163577 | Study of KRN23 Burosumab a Recombinant Fully Human Monoclonal Antibody Against Fibroblast Growth Factor 23 FGF23 in Pediatric Subjects With X-linked Hypophosphatemia XLH | View | |
| NCT02304367 | Study of Burosumab KRN23 in Adults With Tumor-Induced Osteomalacia TIO or Epidermal Nevus Syndrome ENS | View | |
| NCT02705573 | Effects of Mannitol on Delayed Graft Function After Cadaveric Renal Transplantation | View | |
| NCT03182699 | Effect of Etelcalcetide on Cardiac Hypertrophy in Hemodialysis Patients | View | |
| NCT02212262 | Role of Osteocytes in Myeloma Bone Disease | View | |
| NCT02751099 | Bone and Cardiovascular Disease After Kidney Transplant | View | |
| NCT02312687 | Long-Term Extension Study of KRN23 in Adult Subjects With X-Linked Hypophosphatemia XLH | View | |
| NCT00764816 | Effect of Dietary Protein Source on Phosphaturia PTH and FGF23 in Patients With CKD 3 and 4 | View | |
| NCT02598635 | Effects of Cholecalciferol on Osteoprotegerin Levels in Patients on Peritoneal Dialysis | View | |
| NCT02616627 | Association Between DXA Results and the Complications Clinical Courses and Outcomes in Chronic Dialysis Patients | View | |
| NCT02620449 | Impact of Lowering Phosphate Additive Intake on Metabolism and Cardiovascular Health in Community-Living Adults | View | |
| NCT02792413 | Study Evaluating Denosumab on Bone and Vascular Metabolism in Osteoporotic Chronic Kidney Disease | View | |
| NCT03136705 | Healthy Combine Study | View | |
| NCT03821922 | Fibroblast Growth Factor 23 and Hypertensive Disorder Complicating Pregnancy | View | |
| NCT03993821 | Burosumab for CSHS | View |